Effective management of attention-deficit/hyperactivity disorder (ADHD) through structured re-assessment: the Dundee ADHD Clinical Care Pathway
David Coghill, Sarah Seth
CHILD AND ADOLESCENT PSYCHIATRY AND MENTAL HEALTH | BMC | Published : 2015
Under the direction of the authors, Alyson Bexfield, PhD, an employee of Caudex, provided writing assistance for this review. Editorial assistance in formatting, proofreading and copy editing was also provided by Caudex. The authors wish to thank Martin Markarian, an employee of Shire, Switzerland at the time of manuscript development, for his valuable contribution regarding evidence-based treatment approaches. Shire International GmbH, Switzerland provided funding to Caudex, Oxford, UK, for support in writing, editing, coordination and collating comments for this manuscript. Although Shire was involved in the topic concept, the content of this manuscript, the ultimate interpretation, and the decision to submit it for publication in Child and Adolescent Psychiatry and Mental Health was made by the authors independently. Shire supports the responsible use of medications for the treatment of ADHD. Shire does not endorse the off-label use of ADHD medications.